Ann: Final Director's Interest Notice, page-37

does not look good then, I agree when looking at valuation from this analyst.

But why would Perennial buy 4.5 million shares end of Nov for around over 50c if it is worth 19c?

Or does Perennial have no idea? I would think they have done significant research, even spoken to "DOC" especially since they have been buying all through this share price decline, I find this very interesting! time will tell what is actually going on.

On a side note, this new variant will only benefit DOC, anything operating remote is going to do well over coming years.
I suspect we are going to see more variants through 2022, great for Covid stocks, which DOC is.

Looking forward to Jan report, and hopefully double revenue as per guidance.

GLTAH